Autologous tolerogenic dendritic cell therapy (Russian Academy of Sciences)

N/A

Report date: 2022/12/27 09:22:58

Base Information

Drug NameAutologous tolerogenic dendritic cell therapy (Russian Academy of Sciences)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsAutoimmune DiseasesImmune System DiseasesConnective Tissue Diseases +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRussian Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesRussian Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsAutoimmune DiseasesImmune System DiseasesConnective Tissue Diseases +[7] 

Other Information

ATC CodeN/A
Related LinksN/A